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ABSTRACT  
Carbapenem-resistant Enterobacteriaceae(CRE) is a growing 
concern worldwide. The study was conducted to determine the 
prevalence of carbapenem resistant Escherichia coli and Klebsiella 
pneumoniae from urine of suspected urinary tract infected patients 
from (5) General Hospitals within Kaduna metropolis. Following the 
collection of (350) urine samples, Escherichia coli and Klebsiella 
pneumoniae were isolated, identified and characterized using 
selective media (Eosin methylene blue and Macconkey agar), 
biochemical test and microgene kit respectively. Antibiotic 
susceptibility test was carried out for all the isolates using Kirby-
Bauer disc diffusion technique. The isolates that are resistant to 
morepenem and ertapenem were amplified to detect the resistance 
genes. The PCR amplified DNA products were examined for the 
common ESBL-encoding genes (bla TEM and bla SHV) and 
carbapenem resistance genes (blaKPC, blaNDM and blaVIM). In 
all the hospitals, female respondents recorded the highest 
prevalence (74%) than the male (25%). Among the study 
population, Escherichia coli was the most prevalent (28%) followed 
by Klebsiella pneumoniae (13%).Among the five age groups, (≤10, 
11-20, 21-30, 31-40 and 41years and above), (31-40) recorded the 
highest prevalence (5.4%) of Escherichia coli and Klebsiella 
pneumoniae. Among the twelve antibiotics used, Klebsiella 
pneumoniae recorded the highest number of resistant drugs. On 
the prevalence of Escherichia coli and Klebsiella pneumoniae 
resistance to meropenem and ertapenem, (6.1%) was recorded for 
Escherichia coli and (6.5%) for Klebsiella pneumoniae, which is 
slightly higher when compared with the previous report of (5.2%) 
and (2.5%) for Escherichia coli, and (7.8%) and (5.5%) for 
Klebsiella pneumoniae. Following the examination of PCR 
Amplified DNA products, the ESBL genes (bla TEM and blaSHV) 
were detected while for the carbapenemase, only blaVIM gene was 
detected, with the absence of blaKPC and blaNDM genes. 
Detection of these genes constitutes an alarming threat, and have 
been the cause of country-wide epidemics of healthcare associated 
infections. There should be regular and strict monitoring of 
Carbapenem resistance among the Enterobacteriaceae from time 
to time in all general and teaching hospitals, as to curtail the rising 
incidence along with the public health burden associated with these 
resistance genes.  
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Urinary tract infections (UTIs) are one of the most common 
infectious diseases ranking next to upper respiratory tract infection 
(Rubab et al., 2017). It is often associated with significant morbidity 
and mortality (Melaku et al., 2012). UTIs are primarily caused by 
Gram-negative bacteria, but Gram-positive pathogens may also be 
involved. More than 95% of uncomplicated UTIs are monobacterial 
(Sobel 2014). The most common pathogen for uncomplicated UTIs 
is Escherichia coli (75%–95%), followed by Klebsiella pneumoniae, 
Staphylococcus saprophyticus, Enterococcus faecalis, group B 
Streptococci, and Proteus mirabilis(Grude et al., 2001).However, 
E. coli can cause both complicated and uncomplicated UTIs 
(Sobel, 2014). Niranjan et al. (2018) reported a prevalence of 
(44%) among Gram negative Enterobacteriaceae, associated with 
UTI. However, Matar et al. (2008) and Matar et al. (2010), who in a 
study conducted among carbapenem resistant isolates recorded a 
prevalence of (2.5%) for E. coli and (7.8%) for K. pneumoniae. 
Oshun & Ogunsola (2012) reported prevalence of (5.2%) at the 
Lagos University Teaching Hospital, Lagos, Nigeria, while Ogbolu 
& Webber (2014) recorded a lower prevalence of (5.5%)from 
Tertiary Hospitals in Nigeria. 
 
In recent years, the global spread of extended spectrum beta-
lactamase (ESBL)-producing E. coli such as CTX-M-15 has 
emerged as a significant cause of community-associated UTIs 
(Sobel, 2014; CDC, 2017). Highly antibiotic- resistant 
uropathogens, including AmpC β-lactamase- or carbapenemase-
producing Enterobacteriaceae (e.g., New Delhi metallo-β-
lactamase (NDM) and Acinetobacter spp., are increasingly being 
reported among health care associated complicated UTIs (Sobel, 
2014). Carbapenem-resistant Enterobacteriaceae (CRE) is a 
growing concern worldwide (Nordmann 2011). An isolate is 
considered a CRE if it’s resistant to imipenem, meropenem, 
doripenem, or ertapenem by susceptibility testing or if it is identified 
to have a carbapenemase gene (CDC, 2017). The CDC is tracking 
CRE types such as K. Pneumoniae carbapenemase (KPC), NDM, 
IMP-1, and OXA β-lactamases. Among these, KPC is the most 
prevalent type in the United States, and NDM is the most antibiotic 
resistant type, often resistant to new cephalosporin/β-lactamase 
inhibitor combinations (Yusuf et al., 2015; CDC, 2017). 
 
Globally, multidrug resistance has reached an alarming stage and 
WHO has described it as one of the three most serious problems 
confronting human health (WHO, 2014). In Nigeria there have been 
reports of carbapenemase producing clinical isolates of enteric 
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2012). Mathers et al. (2013) reported two cases of orthotopic liver 
transplant recipients that died as a result of infections caused by 
KPC-producing K. pneumoniae. 
Carbapenems are a class of β-lactam antibiotic and exhibit a 
bactericidal activity. They act by binding to penicillin binding 
proteins (PBP), thus preventing the linking of peptidoglycan strands 
and further synthesis of the bacterial cell wall (Kimbery, 2008). 
They are known to be most effective against Gram negative 
bacterial infections (Freeman et al., 2015). 
 
Carbapenem in combination with other agents, remain a mainstay 
of therapy in patients with serious hospital acquired infections. The 
introduction of carbapenem into clinical practice represents a great 
advancement for the treatment of β-lactam resistant bacteria. This 
is due to their broad spectrum of activity and stability to hydrolysis 
by most β-lactamases, the carbapenem have been the drug of 
choice for treatment of infections caused by penicillin or 
cephalosporin resistant Gram negative bacilli (Jesudason et al., 
2009). However, Bacterial resistance to carbapenems is due to the 
production of carbapenem hydrolyzing enzymes called 
carbapenemases, and have the potential to spread rapidly across 
continents (Maletis et al.,2012). Carbapenem resistance is 
produced via 3 mechanisms, namely: reduced permeability, efflux, 
and synthesis of carbapenem β-lactamases (James, 2008; Evan et 
al., 2012). 
 
The aim of this study was to determine the prevalence of 
Carbapenem resistant E. coli and K. pneumoniae in urine samples 
from patients suspected with urinary tract infection from selected 
general hospital within Kaduna metropolis. 
 
MATERIALS AND METHODS 
 
Study Area.  
The study was conducted in Kaduna metropolis, Kaduna State, 
located in North Western Nigeria at latitude 10°31'35.1'' N 
longitude 7°26'19.6'' E (Ashafa, 2004).Its metropolis comprises of 
Kaduna North, Kaduna South and some part of Chikum and Igabi 
local Government. Selected Hospitals are; General Hospital Kawo, 
Yusuf Dantsoho Memorial Hospital Tudun Wada, Barau Dikko 
Teaching Hospital Kaduna State University (KASU), Gwamna 
Awan General Hospital Kakuri and General Hospital Sabon Tasha. 
 
Sample Size   




Where, no is the sample size, z is the selected critical value of 
desired confidence level, p is the estimated proportion of an 
attribute that is present in the population, q = 1 – p and e is the 
desired level of precision. The sample of the study was determined 
using the prevalence rate of carbapenem resistance of 9.3% 
(Motayo et. Al., 2013). Sample size of (196) was calculated, but 
was rounded up (350) samples  
p =0.5 
q = 1-0.5 = 0.5 e = 0.05 z = 1.96, and  
n = (1,96) 
 
Inclusion Criteria 
Patients sent to the Microbiology laboratory with a suspected cases 
of Urinary Tract Infection were included in this study. 
 
Exclusion Criteria 
Patients sent to the Microbiology laboratory for suspected cases 
other than Urinary Tract Infection and Patients that did not want to 
participate were excluded. 
 
Ethical Approval 
Ethical approval was obtained from the Ethical Committee, Kaduna 
State Ministry of Health and Human Services, and Ethical 
Committee of Barau Dikko Teaching Hospital Kaduna State 
University. 
 
Administration of Questionnaire 
Semi-structured questionnaires were administered to the patients 
that fulfilled the inclusion criteria, to capture their demographic 
information, such as sex, age, sexual contact and medical history. 
 
Sample Collection and Processing 
A total of 350 urine samples were collected from patients sent to 
Microbiology laboratory of the selected hospitals within Kaduna 
metropolis. All the samples collected were processed according to 
standard operating procedure. The samples were inoculated on 
selective and differential agar and incubated overnight at 37ºC. 
 
Cultural and Microscopic Characteristics 
Isolates were identified by their morphological characteristics on 
MacConkey agar and Eosin Methylene blue agar. Pink mucoid 
colonies and flat dry circle pink colonies on MacConkey and 
colonies with green metallic sheen on Eosin methylene blue agar 




Thin Smears were prepared from a 24h culture, air-dried and heat-
fixed by passing the slide over a Bunsen flame for three quick 
successions. The smears were Gram stained and examined 
microscopically under oil immersion objective lens following the 
addition of oil immersion (Cowans & Still, 2004). 
 
Biochemical test 
For further reconfirmation, suspected colonies of E. coli and K. 
pneumoniae were subjected to a number of biochemical tests 
which includes; Indole test, Methyl Red - Voges-Proskauer test, 
citrate utilizations test, urease test, Catalase test, motility test, 
hydrogen Sulphide Production along with carbohydrate 
fermentation test (Glucose, Lactose, Sucrose, and Mannitol 
fermentation) (Cheesbrough, 2000). 
 
Antibiotic Susceptibility test 
Biochemically characterized isolates of E. coli and K. pneumonia 
were standardized by inoculating the isolates into a nutrient broth. 
The broth was incubated at 37°C until the visible turbidity matches 
that of 0.5 McFarland standard. Using the modified Kirby-Bauer 
disc diffusion technique, the standardized isolates were inoculated 
in an already prepared Mueller Hinton agar, and the sensitivity disc 
were gently placed on the agar surface. The antibiotic discs used 
were Meropenem (10ug), Artapenem (10ug), Ciprofloxacin (30ug), 
Septrin(30ug), Chloropenicol (30ug), Gentamycin (30ug), 
Streptomycin (30ug), Pefloxacin (30ug), Augmentin (10ug), 
Amoxicillin (30ug), Sparfloxacin (10ug) and Tarivid (10ug) (CLSI, 
2009). Isolates that are resistant to Meropenem and Ertapenem 
were investigated to detect for the resistance gene using Multiplex 
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Molecular Detection of Resistance Genes 
Genomic DNA extraction 
An overnight suspension of the bacterial isolateswas prepared in a 
sterile 2.0mL ependorf tube containing 1.8 mL of brain heart 
infusion broth. The tubes were centrifuged at 14000 rpm for 1 
minute. The supernatant was discarded and the cells were 
resuspended in 300 uL of nuclease free water. DNA was extracted 
from the suspension using qiagen DNA extraction kit (QIAamp 
DNA minikit of 50), following the manufacturer’s instructions. 
 
Primers 
Table 1: Primer sets for amplification of carbapenemase and 
extended spectrum betalactamase genes 
 
Key: 
VIM: Verona integron-encoded metallo-β-lactamase, NDM: New 
Delhi metallo-β-lactamase, KPC: Klebsiellapneumoniae 
carbapenemase, TEM-1, Temoniera-1; SHV -1, sulphydry1 
variable-1 
 
Multiplex Polymerase Chain Reaction (PCR). 
The primers were used to amplify internal fragments with sizes from 
232 to 798 bp, as presented in Table 1.For easy interpretation, to 
avoid similar-in-size amplicons for a given PCR tube, and to 
maintain clinical relevance of the screening (combining together 
the most widely distributed genes in clinical isolates), 2 multiplex 
reactions were defined, with no. 1 including detection of TEM and 
SHV with the expected amplicon size of 293-bp and 403-bp 
respectively. The second multiplex PCR including detection of 
blaVIM, blaNDM, blaKPC with expected amplicon size of 390-bp, 
621-bp and 798-bp respectively. Amplification was carried out with 
the following thermal cycling conditions: 10 min at 94°C and 36 
cycles of amplification consisting of 30 s at 94°C, 40 s at 52°C, and 
50 s at 72°C, with 5 min at 72°C for The final extension (Poirel et 
al., 2011). 
 
Agarose Gel electrophoresis 
Amplified products were analyzed by electrophoresis in a 2% 
agarose gel at 100 V for 60 min 1× TAE (40 mmol/L Tris–HCl 
[pH8.3], 2 mmol/L acetate, 1 mmol/L EDTA) containing 0.05 mg/L 
ethidium bromide. A 100-bp from Dongsheng Biotech, China was 
used as DNA ladder. Following electrophoresis, the gel was 
transferred to a Biorad- gel documentation device and viewed 
using the U.V Trans illuminator (Poirel et. Al., 2011). 
 
Statistical Analysis 
Results obtained were presented in charts, tables, and graphs 
where applicable. The result was further analyzed statistically using 
χ2 at 95% confidence interval. 
 
RESULT 
Table 2 shows the occurrences of Escherichia coli and Klebsiella 
pneumoniae isolates from the urine samples. Out of 350 subjects 
analysed, 96 Escherichia coli and 46 Klebsiella pneumoniae were 
isolated. 
 
Table 2: Occurrences of Escherichiacoli and Klebsiella 
pneumoniae in urine Samples collected from (5) General hospital 
within Kaduna metropolis 
 
Key:  
GHK General Hospital Kawo, BDTH: Barau Dikko Teaching 
Hospital, YMDH: 
Yusuf Dantsoho Memorial Hospital, GAGH: General Hospital 
Sabon Tasha. 
 
Table 3 shows the percentage distribution of Escherichia coli and 
Klebsiella pneumoniae among male and female patients from the 
selected General Hospitals within Kaduna metropolis. Out of 98 
Escherichia coli isolated 29 where from male patients and 69 from 
female patients, while Klebsiella pneumoniae out of 46, 8 for male 
patients and 38 for female patients. 
 
Table 3: Distribution of E. coli and K. pneumoniae among Male and 




Table 4 shows the distribution of Escherichia coli and Klebsiella 
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Table 4: Distribution of E coli and K. pneumoniae among Male and 
Female of different age groups 
 
 
Table 5 shows the antimicrobial susceptibility patterns of 
Escherichia coli from urine samples of patients in selected general 
hospital within Kaduna metropolis. The various zone of inhibitions 
were measured and compared with the new standard guidelines of 
clinical and laboratory standards institute (CLSI) 2018.  
Meropenem and ertapenem having the highest sensitivity profile of 
Escherichia coli 95.92% and 97.96%. 
 
Table 5: Antimicrobial susceptibility profile of E. coli from urine 




MEM= Meropenem, ETP= Ertapenem, SXT= Septrin, 
CH=Chloramphenicol, SP= Sparfloxacin, OFX= Tarivid, S= 
Streptomycin. 
 
Table 6 shows the antimicrobial susceptibility patterns of Klebsiella 
pneumonia from urine samples of patients in selected general 
hospital within Kaduna metropolis. The various zone of inhibitions 
were measured and compared with the new standard guidelines of 
clinical and laboratory standards institute (CLSI) 2018.  
Meropenem and ertapenem having the highest sensitivity profile of 
Klebsiella pneumoniae with 97.83% and 95.65%. 
 
Table 6: Antimicrobial susceptibility profile of K. pneumoniae from 




MEM= Meropenem, ETP= Ertapenem, SXT= Septrin, 
CH=Chloramphenicol, SP= Sparfloxacin, OFX= Tarivid, S= 
Streptomycin. 
 
Table 7 shows the prevalence of meropenem and ertapenem 
resistant E.coli and Klebsiella pneumoniae from the sample 
analysed.  
 
Table 7: Prevalence of Meropenem and Ertapenem resistant E. 
coli and K. pneumoniae from the Samples Analysed. 
 
 
Plate 1 shows the agarose gel electrophoresis detection of the 
resistant gene blaKPC, blaNDM and blaVIM from the resistant 
isolates. The lane M is the DNA marker leader of 100bp, lane 2 to 
7 shows the wells of multiplex PCR products and lane 8 shows the 
negative control. 
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Plate 1: Agarose gel electrophoresis of blaKPC, blaNDM, and 
blaVIM (multiplex PCR) of the resistant genes of bacteria 
recovered from urine samples analysed. Where well M (DNA 
marker, 100bp, Biolabs New England)), 1,2,3,4 and 5 are sample 
Wells and 6 Negative control. 
 
Plate 2 shows the agarose gel electrophoresis detection of the 
resistant gene blaTEM and blaSHV from the resistant isolates. The 
lane M is the molecular marker leader of 100bp, lane 2-6 sample 
wells and 7 negative control. 
 
 
Plate2: Agarose gel electrophoresis of blaTEM and blaSHV 
(multiplex PCR) of the resistant gene of the bacteria recovered from 
urine samples analysed. Well M (DNA marker (100bp, Biolabs New 




Out of the 350 samples collected, 144(41%) positive samples were 
recorded, with E. coli having 98 (28%) and K. pneumoniae having 
46 (13%), making E. coli the most prevalent organism among all 
the entire study population. From all the hospitals, Barau Dikko 
Teaching Hospital recorded the highest number of positive 
samples 34(9%), while General Hospital Kawo and Yusuf 
Dantsoho Memorial Hospital recorded the lowest number of 
negative samples 26 (7%). 
However, from  all the hospitals, Barau Dikko Teaching Hospital 
and Gwamna Awan General Hospital had the highest occurrence 
of E. coli 25 (7%),and K. Pneumoniae 12 (3%)respectively. General 
Hospital Kawo and Yusuf Dantsoho Memorial Hospital had the 
lowest occurrence of E. coli 16 (4%), and K. pneumoniae 
05(1%)respectively (Table 1).  
The higher number of E. coli (98) and K. pneumoniae (46) recorded 
in the urine samples analysed agrees with the report of May et al. 
(2015) who stated that E. coli and K. pneumoniae are the most 
frequent Enterobacteriaceae associated with urinary tract 
infections. 
The result is similar with the findings of Aswani et al. (2014) who 
also reported a varying occurrence of different isolates among 
different study area in Nigeria. However, the variations in the 
number of positive samples, along with the variation in the isolates 
occurrence from among the different hospitals might be due to the 
fact that a number of species of Enterobacteriaceae are 
responsible for urinary tract infections (Niranjan et al., 2018; 
Mohamed et al., 2019). 
Niranjan et al. (2018) and May et al. (2015) also reported a higher 
occurrence of E. coli and K. pneumoniae among females, 
compared to their male counterparts. The higher occurrence of 
these isolates among females as presented in (Table 2) might be 
attributed to; the organisms easy passage to the bladder, their 
shorter urethra compared to their male counterparts along with 
sexual contact, which may cause UTI, as the bacteria can be 
pushed into their urethra. However, Niranjan et al. (2018) reported 
a prevalence of (44%) among Gram negative Enterobacteriaceae, 
which is a bit higher than the prevalence reported for E. coli (29.6%) 
and lower than that reported for K. pneumoniae (70%) in this study. 
The high number of these isolates among patients of different age 
groups (≤10, 11-20, 21-30, 31-40 and 41years and above), 
presented with UTI (Table 3), can be attributed to the fact that E. 
coli and K. pneumoniae are the commonest isolates implicated 
among patients with (UTI) (Melaku et al., 2012; Sharma & Paul, 
2012). The high occurrence of the isolates among females, is in 
line with the findings of May et al. (2015) who reported that females, 
compared to their male counterparts experience much occurrence 
of urinary tract infections (UTI’s). 
Out of a total number of (98) E. coli isolates tested against various 
antibiotics (Table 4), meropenem, ertapenem, septrin, gentamycin, 
and streptomycin recorded a higher number of susceptible isolates, 
while chloramphenicol, sparfloxacin, ciprofloxacin, amoxicillin, 
Augmentin, pefloxacin, and tarivid have a higher number of 
resistant isolates. 
Among the K. pneumoniae, out of total of (46) positive isolates 
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tested each among the various antibiotics (Table 5), a higher 
number of resistant isolates were recorded among; septrin, 
chloramphenicol, sparfloxacin, ciprofloxacin, amoxicillin, 
Augmentin, gentamycin, pefloxacin, and tarivid antibiotics, while 
meropenem, ertapenem and streptomycin recorded a higher 
number of susceptible isolates. The high level of susceptibility 
demonstrated to (chloramphenicol, sparfloxacin, ciprofloxacin, 
amoxicillin, Augmentin, pefloxacin, and tarivid, in this study agrees 
with the study of Chikwendu et al. (2010) Osundiya et al. (2013). 
Among the twelve different antibiotics tested against the two 
isolates (Table 4 and 5), E. coli recorded the highest number of 
drugs (5 antibiotics) been susceptible to the isolates with K. 
pneumoniae having the least (3 antibiotics). Furthermore, K. 
pneumoniae recorded the highest number of drugs (9 antibiotics) 
been resistant to the isolates with E. coli having the least (7 
antibiotics). The result is in line with the findings of Eshetie et al. 
(2015), who reported that the emergences of multi drug resistance 
among enterobacteriaceae were mainly due to the production of 
enzymes, such as carbapenemases and that this carbapenemase 
production is one of the main mechanisms in the occurrence of 
drug resistance in the family of Enterobacteriaceae. 
On the prevalence rate of meropenem and ertapenem among E. 
coli isolates (Table 6), out of a total number of (98), higher number 
of susceptible isolates were recorded with a prevalence rate of 
(93.8%) representing (92) samples and a lower prevalence rate on 
the resistant isolates having (6.1%) representing (6) isolates. 
However, on the prevalence of meropenem and ertapenem among 
K. pneumoniae (Table 6), out of a total number of (46) samples, 
(n=46), higher number of susceptible isolates were recorded, with 
a prevalence rate of (93%) representing (43) isolates and a lower 
prevalence rate on the resistant isolates, having (6.5%) 
representing (3) isolates.  The prevalence rate of meropenem and 
ertapenem resistant E. coli and K. pneumoniae having (6%) and 
(6.5%), is slightly higher when compared with the report of Ogbolu 
& Webber (2014) who recorded a prevalence rate of (5.5%).  
However, the prevalence of carbapenems recorded in this study 
varies with the findings of Matar et al. (2010), who in a study 
conducted among carbapenem resistant isolates recorded a 
prevalence of (2.5%) for E. coli and (7.8%) for K. pneumoniae. 
Similarly, the results also vary with the findings of Oshun & 
Ogunsola (2012), who reported a carbapenem prevalence rate of 
(5.2%), and Eshetie et al. (2015) reported a higher prevalence of 
(61.2%) for E. coli and a lower prevalence of (15.8%) for K. 
pneumoniae. Similar variation was also observed upon comparison 
with the findings of Niranjan et al. (2018) who reported a higher 
prevalence of (49.8%) and (37.4%) for both E. coli and K. 
pneumoniae respectively. 
This shows that the carbapenemase resistance is on rapid increase 
in Nigeria, and this may be as a result of unawareness of their 
occurrence, effects but only the consequences is being felt as a 
number of treatment failures have been reported when antibiotics 
such as cephalosporins, penicillins, quinolones are used (Yusuf et 
al., 2012). 
Currently, the increased burden of Multidrug resistant 
Enterobacteriaceae causing (UTI) compounded by harboring 
carbapenem resistance genes mainly among E. coli and K. 
pneumoniae have become a serious threat to public health, as they 
are associated with high mortality rates and have the potential to 
spread widely (Matar et al., 2010). Carbapenem such as imipenem, 
meropenem, ertapenem, and doripenem are considered as the last 
resort antibiotics to treat ESBL producing Enterobacteriaceae 
(Habte et al., 2009). 
However, the high level usage of carbapenems both as prescribes 
by clinicians, along with their indiscriminately use, may have 
contributed to this higher prevalence rate of resistance recorded in 
Kaduna State general hospitals (Codjoe, 2016). Klebsiella 
pneumoniae carbapenemase production is an important 
mechanism of resistance for an increasingly wide range of Gram-
negative bacteria and is no longer limited to K. pneumoniae 
(Hussaini et al., 2017). 
At present, infections caused by Carbapenamases producing 
Enterobacteriaceae (CPE) are difficult, and in some cases 
impossible to treat and have been associated with mortality rates 
up to (50%) (Eshetie et al., 2015). Due to the movement of patients 
throughout the health care system, if (CPE) is a problem in one 
facility, then typically, they are a problem in other facilities in a State 
as well. Carbapenemase producing enterobacteriaceae are mostly 
endemic in specific geographical regions, but reports of their rapid 
spread into other geographical locations are indeed a point of grave 
concern these days (Nordmann et al., 2011). 
The PCR Amplified DNA products were examined for the common 
ESBL encoding genes (bla TEM and blaSHV) and carbapenem 
resistance genes (blaKPC, blaNDM and blaVIM). However, all the 
ESBL genes were detected while for the carbapenemase, only 
blaVIM was detected, with the absence of blaKPC and blaNDM 
genes. 
The presence of bla-VIM, bla TEM (Plate 1) and blaSHV genes 
(Plate 2), among K. pneumoniae and E. coli corresponds with the 
findings of Carrer et al. (2010), Lopez et al. (2011), and Yusuf et al. 
(2015), who reported the presence of these genes among 
hospitalized patients, and other clinical isolates, but varies with the 
findings of Mohamed et al. (2019), who reported the presence of 
blaKPC and blaNDM genes among the isolates. The absence of 
any active control plans to curtail the rising spread of carbapenems 
resistance in Nigeria shows that attentions are not been paid to 
these problems, which is the likely reason for the low level of 
awareness among the medical practitioners in the country (Yusuf 
et al., 2015). 
The detection of ESBL and carbapenem resistant genes among E. 
coli and K. pneumoniae have been reported in Nigeria, and it 
constitutes an alarming threat (Yusuf et al.,2011, Yusuf et 
al.,2015). 
In Nigeria, there is report of phenotypic detection of carbapenem 
resistance among clinical isolates in some hospitals in Kano, North 
west Nigeria (Yusuf et al., in 2011). Nevertheless, carbapenemase-
producing strains of K. pneumoniae harbouring either blaVIM or 
blaKPC have been the cause of country-wide epidemics of 
healthcare associated infections (Nordmann et al., 2009; Yusuf et 
al., 2015).  
However, bla-KPC carbapenem resistant gene producing 
Enterobacteriaceae are often misidentified by routine 
microbiological susceptibility testing and incorrectly reported as 
sensitive to carbapenems; however, resistance to the carbapenem 
antibiotic ertapenem is common and a better indicator of the 
presence of KPCs (Ryan et al., 2011).The NDM-1 gene raised 
global concern since its first recognition in Pakistan and spread to 
many other countries via the movement of people and other 
medical tourists (Health Protection Agency, 2009; Kumarasamy et 
al., 2010). The genes involved in carbapenem resistance among 
Enterobacteriaceae vary greatly among different countries. In 
Lebanon, these carbapenemases are OXA-48 from both K. 
pneumoniae and E. coli (El-Herte et al., 2012). 
104 
Science World Journal Vol. 15(No 4) 2020 
www.scienceworldjournal.org 
ISSN: 1597-6343 (Online), ISSN: 2756-391X (Print)   
Published by Faculty of Science, Kaduna State University 
 
Prevalence of Carbapenem Resistant Escherichia Coli and Klebsiella Pneumoniae 




Out of a total of (350) samples collected, (144) representing (41%) 
positive samples were recorded, with E. coli having (98) 
representing (28%) and K. pneumoniae having (46) representing 
(13%), making E. coli the most prevalent organism among the 
study population. Out of a total of (98) positive samples of E. coli, 
(29) representing (29.6%) and (69) representing (70%) samples 
were positive for E. coli among the male and female patients 
respectively. While out of (46) positive samples for K. pneumoniae, 
a total of (8) representing (17%) and (38) representing (82.6%) 
samples were positive for K. pneumoniae among the male and 
female patients respectively. However, among the five age groups, 
(≤10, 11-20, 21-30, 31-40 and 41years and above), females have 
a higher occurrence of both the E. coli and K. pneumoniae 
infections. Furthermore, (31-40) age group recorded the highest 
occurrence of the isolates, having (39) representing (11%) and (19) 
representing (5.4%) positive samples for E. coli and K. 
pneumoniae. Among the twelve antibiotics tested against the 
isolates, E. coli recorded the highest number of susceptible drugs 
(5 drugs), with K. pneumoniae having the least (3 drugs). 
Furthermore, K. pneumoniae recorded the highest number of 
resistant drugs (9 drugs) with E. coli having the least (7 drugs). On 
the prevalence of meropenem and ertapenem resistance among E. 
coli, a prevalence of (6.1%) (n=98), representing (6) isolates was 
recorded. While for K. pneumoniae, a prevalence of (6.5%) (n=46), 
representing (3) resistant isolates, was recorded.  The prevalence 
recorded is slightly higher when compared with the previous report 
of (5.2%) and (2.5%) for E. coli and (7.8%) and (5.5%) for K. 
pneumoniae. The PCR Amplified DNA products were examined for 
the common ESBL encoding genes (bla TEM and blaSHV) and 
carbapenem resistance genes (blaKPC, blaNDM and blaVIM). 
However, all the ESBL genes were detected while for the 
carbapenemase, only blaVIM was detected, with the absence of 
blaKPC and blaNDM genes. Detection of these genes constitutes 
an alarming threat, and have been the cause of country-wide 
epidemics of healthcare associated infections. The absence of any 
active control plans to curtail the rising spread of carbapenems 
resistance in Nigeria shows that attentions are not been paid to 
these problems, which is the likely reason for the low level of 
awareness among the medical practitioners in the country. 
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